Our succes in integrating information into models that generate unique insights, allowing executives to make better drug development decisions, is reflected in our gold-standard research publications.
Latest publications
Exposure-response relationships of mirvetuximab soravtansine in patients with folate receptor-alpha-positive ovarian cancer: Justification of therapeutic dose regimen | Oncology
		
			Tu YP
							,  Lagraauw HM			
			|
			qP contributors: Lagraauw HM, Hanze E		|
		2025|
		Journal|
		British Journal of Clinical Pharmacology
					
								Link			
		
			
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY | Oncology
		
			Kuchimanchi M
							,  Jorgensen TL			
			|
			qP contributors: Hanze E, Alskar O		|
		2025|
		Journal|
		British Journal of Clinical Pharmacology
					
								Link			
		
			
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite | Oncology
		
			Tu YP
							,  Hanze E			
			|
			qP contributors: Hanze E, Lagraauw HM		|
		2024|
		Journal|
		British Journal of Clinical Pharmacology
					
								Link			
		
			
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations | Pediatrics
		
			Schaedeli Stark F
							,  Chavanne C			
			|
			qP contributors: Jolling K, Lagraauw HM, Lindbom L, Prins K		|
		2024|
		Journal|
		Journal of Pharmacokinetics and Pharmacodynamics
					
								Link			
		
			
Mechanism-Based Modeling of Perioperative Variations in Hemoglobin Concentration in Patients Undergoing Laparoscopic Surgery | Hematology
		
			Jaramillo S
							,  Marco-Arino N			
			|
			qP contributors: Marco-Arino N		|
		2024|
		Journal|
		Anesthesia & Analgesia
					
								Link			
		
			
A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders | Haematology
		
			Gandhi P.S
							,  Zivkovic M			
			|
			qP contributors: Alskar O		|
		2024|
		Journal|
		Nature Cardiovascular Research
					
								Link			
		
			
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants | CNS
		
			Rucker JJ
							,  Roberts C			
			|
			qP contributors: Suttle B		|
		2024|
		Journal|
		Journal of Psychopharmacology
					
								Link			
		
			
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians | Pediatrics
Modeling and Simulations in Latin-American Generic Markets: Perspectives from Chilean Local Industry, Regulatory Agency, and Academia | All
A Phase I Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Liposomal Bupivacaine for Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy | Analgesia
		
			Sessler DI
							,  Bao X			
			|
			qP contributors: Voelkner A		|
		2024|
		Journal|
		Journal of Clinical Pharmacology
					
								Link			
		
			
